Counselors in Loa, UT Accepting Medicare
8 Counselors found. Showing 1 - 8
 Devon Christopher Nanton, SUDC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 92 W. Main St, Loa, UT 84747 Phone: 435-836-2272 Fax: 435-836-2274 |
Mr. Michael Edgar Porter Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 57 South Main, Loa, UT 84747 Phone: 435-624-3304 |
Derek J Daley Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 56 South Main St, Loa, UT 84747 Phone: 801-358-2974 |
Michael Steven Petree, ACMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 56 South Main Street, Loa, UT 84747 Phone: 435-836-2273 |
Jake Giffuni Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 1764 West Aspen Lane, Loa, UT 84747 Phone: 435-836-2272 |
David Wieder, CMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1764 W Aspen Lane, Loa, UT 84747 Phone: 505-231-5031 |
 Ms. Veronica Malencia Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1764 W Aspen Lane, Loa, UT 84747 Phone: 435-836-2272 |
Rachel Rollins, ACMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1764 W Aspen Lane, Loa, UT 84747 Phone: 508-259-0585 |
News Archive
NanoLogix BNP and BNF Quick Test kits detect, identify Group B Strep in four to six hours
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell bacteria and microorganisms, announced today that the American Journal of Perinatology has published a peer-reviewed paper from the University of Texas Health Science Center - Houston confirming NanoLogix BioNanoPore (BNP) and BioNanoFilter (BNF) Quick Test technology detect and identify Group B Strep in four to six hours.
Pernix first quarter net revenues increase 14% to $10.1 million
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced financial results for the first quarter of 2011.
Hospital design and effective decontamination can prevent spread of antibiotic-resistant infections
Hospitals should design premises and adapt their infection control routines to a society that no longer has effective antibiotics, and that is vulnerable to fast-spreading global pandemics. This is argued in a new dissertation from Lund University in Sweden.
FAU awarded $2.1 million to examine effectiveness of antipsychotic medication for schizophrenia
Florida Atlantic University's Charles E. Schmidt College of Medicine was recently awarded a $2.1 million, two-year contract by Otsuka America Pharmaceutical Inc. to conduct a study to examine the effectiveness of an injectable long-acting antipsychotic medication for schizophrenia and its impact on 30-day hospital readmission rates.
Odor alters how memories are processed in the brain, research reveals
In a new paper published in Learning and Memory, researchers from Boston University's Center for Systems Neuroscience reveal just how much power scents have in triggering the memory of past experiences-and the potential for odor to be used as a tool to treat memory-related mood disorders.
› Verified 3 days ago